Myovant Sciences Ltd. 3 SEC Filings

Filed On	Filing
21 Oct 2022	Form 3: Nishinaka Shigeyuki, Director Holds 0 shares of Common Shares
09 Nov 2021	Form 3: Valente Nancy, Director Holds 0 shares of Common Shares
09 Sep 2021	Form 3: Mehra Uneek, Principal Financial Officer Holds 0 shares of Common Shares
08 Apr 2021	Form 3: Merendino Lauren, Chief Commercial Officer Holds 0 shares of Common Shares
12 Jan 2021	Form 3: Marek David C, Director Holds 0 shares of Common Shares
03 Jan 2020	Form 3: Sumitomo Chemical Co., Ltd., 10% owner and 2 others Holds 45,008,604 shares of Common Stock
30 Dec 2019	Form 3: Nomura Hiroshi, Director Holds 0 shares of Common Shares
30 Dec 2019	Form 3: Gulfo Adele M., Director Holds 0 shares of Common Shares
10 Jan 2019	Form 3: Viking Global Equities Master Ltd., 10% owner Holds 38,341,357 shares of Common Shares, $0.00001 par value per share
03 Dec 2018	Form 3: Sablich Kim, Chief Commercial Officer Holds 0 shares of Common Shares
08 Nov 2018	Form 3: Torti Frank, Director Holds 0 shares of Common Shares
24 Sep 2018	Form 3: Potter Myrtle S, Director Holds 0 shares of Common Shares
24 Jul 2018	Form 3: Guinan Mark, Director Holds 0 shares of Common Shares
04 Apr 2018	Form 3: Dexcel Pharma Technologies Ltd., 10% owner Holds 37,231,342 shares of Common Shares, $0.000017727 par value per share
29 Mar 2018	Form 3: Millennium Pharmaceuticals Inc, 10% owner and 1 other Holds 7,420,625 shares of Common Stock
14 Sep 2017	Form 3: Svf Investments (UK) Ltd, 10% owner and 3 others Holds 37,231,342 shares of Common Shares
09 Aug 2017	Form 3: Ferreira Juan Camilo Arjona, Chief Medical Officer Holds 0 shares of Common Shares
18 Jul 2017	Form 3: Lang Matthew, General Counsel & Corp. Secy. Holds 0 shares of Common Stock
10 Jul 2017	Form 3: Shabet Rose Sharon, 10% owner Holds 37,231,342 shares of Common Shares, $0.00001 par value per share
17 Nov 2016	Form 3: Curran Terrie, Director Holds 0 shares of Common Shares

Comments